pentetic acid has been researched along with Cancer of Gastrointestinal Tract in 26 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Recently, we have shown that the expression of receptors for vasoactive intestinal peptide (VIP) on intestinal adenocarcinomas can be used for in vivo targeting of primary or metastatic tumor sites using 123I-labeled VIP." | 5.08 | Comparison of iodine-123-vasoactive intestinal peptide receptor scintigraphy and indium-111-CYT-103 immunoscintigraphy. ( Angelberger, P; Becherer, A; Kletter, K; Kornek, G; Kurtaran, A; Leimer, M; Li, S; Raderer, M; Scheithauer, W; Virgolini, I; Weinlaender, G, 1996) |
| "They can be subdivided into the carcinoid tumors of the gastrointestinal submucosa and the islet cell endocrine tumors of the pancreas." | 2.40 | Recent advances in diagnosis and therapy of neuroendocrine tumors of the gastrointestinal tract. ( Bukowski, RM; Pelley, RJ, 1997) |
| "Primary cultures of gastric carcinoid, midgut carcinoid and glucagonoma cells were incubated with 111In-DTPA-D-Phe1-octreotide and cell-surface bound, internalized and released 111In activity was measured." | 1.29 | Internalization of indium-111 into human neuroendocrine tumor cells after incubation with indium-111-DTPA-D-Phe1-octreotide. ( Ahlman, H; Andersson, P; Fjälling, M; Forssell-Aronsson, E; Johanson, V; Nilsson, O; Wängberg, B, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (7.69) | 18.7374 |
| 1990's | 16 (61.54) | 18.2507 |
| 2000's | 8 (30.77) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Namwongprom, S | 1 |
| Wong, FC | 1 |
| Tateishi, U | 1 |
| Kim, EE | 1 |
| Boonyaprapa, S | 1 |
| Dimitroulopoulos, D | 1 |
| Xynopoulos, D | 1 |
| Tsamakidis, K | 1 |
| Paraskevas, E | 1 |
| Zisimopoulos, A | 1 |
| Andriotis, E | 1 |
| Fotopoulou, E | 1 |
| Kontis, M | 1 |
| Paraskevas, I | 1 |
| Kwekkeboom, DJ | 4 |
| Mueller-Brand, J | 1 |
| Paganelli, G | 1 |
| Anthony, LB | 1 |
| Pauwels, S | 2 |
| Kvols, LK | 1 |
| O'dorisio, TM | 1 |
| Valkema, R | 2 |
| Bodei, L | 1 |
| Chinol, M | 1 |
| Maecke, HR | 1 |
| Krenning, EP | 5 |
| Teunissen, JJ | 1 |
| de Jong, M | 1 |
| Esser, JP | 1 |
| Van Eijck, CH | 2 |
| Oei, HY | 2 |
| de Jong, RJ | 1 |
| Dop, FJ | 1 |
| de Herder, WW | 1 |
| Reubi, JC | 2 |
| Lamberts, SW | 3 |
| Eising, EG | 1 |
| Farahati, J | 1 |
| Bier, D | 1 |
| Knust, EJ | 1 |
| Reiners, C | 1 |
| Weinel, RJ | 1 |
| Kisker, O | 1 |
| Joseph, K | 2 |
| Welcke, U | 1 |
| Zaraca, F | 1 |
| Rothmund, M | 1 |
| Leners, N | 1 |
| Fiasse, R | 1 |
| Jamar, F | 1 |
| Ahlman, H | 2 |
| Tisell, LE | 1 |
| Wängberg, B | 2 |
| Nilsson, O | 2 |
| Forssell-Aronsson, E | 2 |
| Fjälling, M | 2 |
| Wiedenmann, B | 1 |
| Bäder, HM | 1 |
| Scherubl, H | 1 |
| Fett, U | 1 |
| Zimmer, T | 1 |
| Hamm, B | 1 |
| Koppenhagen, K | 1 |
| Riecken, EO | 1 |
| Adrian, HJ | 1 |
| Dörr, U | 1 |
| Bach, D | 1 |
| Bihl, H | 1 |
| Stapp, J | 1 |
| Reinecke, J | 1 |
| Skamel, HJ | 1 |
| Höffken, H | 1 |
| Neuhaus, C | 1 |
| Lenze, H | 1 |
| Trautmann, ME | 1 |
| Arnold, R | 1 |
| van Hagen, PM | 1 |
| Chayvialle, JA | 1 |
| Raderer, M | 1 |
| Becherer, A | 1 |
| Kurtaran, A | 1 |
| Angelberger, P | 1 |
| Li, S | 1 |
| Leimer, M | 1 |
| Weinlaender, G | 1 |
| Kornek, G | 1 |
| Kletter, K | 1 |
| Scheithauer, W | 1 |
| Virgolini, I | 1 |
| Andersson, P | 1 |
| Johanson, V | 1 |
| Pelley, RJ | 1 |
| Bukowski, RM | 1 |
| Chiti, A | 1 |
| Spinelli, A | 1 |
| Bombardieri, E | 1 |
| Schillaci, O | 1 |
| Corleto, VD | 1 |
| Annibale, B | 1 |
| Scopinaro, F | 1 |
| Delle Fave, G | 1 |
| Banzo, J | 1 |
| Abós, MD | 1 |
| Prats, E | 1 |
| García, F | 1 |
| Razola, P | 1 |
| Anderson, CJ | 1 |
| Dehdashti, F | 1 |
| Cutler, PD | 1 |
| Schwarz, SW | 1 |
| Laforest, R | 1 |
| Bass, LA | 1 |
| Lewis, JS | 1 |
| McCarthy, DW | 1 |
| Ichijo, T | 1 |
| Ishikawa, M | 1 |
| Shimojo, M | 1 |
| Tsubuku, M | 1 |
| Tsuboi, K | 1 |
| Miyachi, Y | 1 |
| Hosten, N | 1 |
| Schörner, W | 1 |
| Schubeus, P | 1 |
| Felix, R | 1 |
| Chu, TM | 1 |
| Abdel-Dayem, HM | 1 |
| Mahajan, KK | 1 |
| Ericsson, SB | 1 |
| Kouris, K | 1 |
| Owunwanne, A | 1 |
| Nawaz, K | 1 |
| Higazi, E | 1 |
| Awdeh, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Peptide Receptor Radionuclide Therapy (PRRT) in Tumors With High Expression of Somatostatin Receptors[NCT04790708] | 250 participants (Anticipated) | Interventional | 2018-07-02 | Recruiting | |||
| Molecular and Whole-body MR Imaging in Lymphomas[NCT02389101] | 21 participants (Actual) | Interventional | 2014-10-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Uptake of 68Ga-DOTANOC in lymphoma expressed as SUVmax (NCT02389101)
Timeframe: Within 30 days prior to start of chemotherapy
| Intervention | Standardized Uptake Value (Median) |
|---|---|
| Lymphoma | 3.1 |
8 reviews available for pentetic acid and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.
Topics: Animals; Clinical Trials as Topic; Drug Delivery Systems; Drug Evaluation, Preclinical; Gastrointest | 2005 |
Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.
Topics: Animals; Clinical Trials as Topic; Drug Delivery Systems; Drug Evaluation, Preclinical; Gastrointest | 2005 |
Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.
Topics: Animals; Clinical Trials as Topic; Drug Delivery Systems; Drug Evaluation, Preclinical; Gastrointest | 2005 |
Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.
Topics: Animals; Clinical Trials as Topic; Drug Delivery Systems; Drug Evaluation, Preclinical; Gastrointest | 2005 |
Endocrine tumours of the gastrointestinal tract. Peptide receptor radionuclide therapy.
Topics: Animals; Carcinoma, Neuroendocrine; Gastrointestinal Neoplasms; Humans; Indium Radioisotopes; Luteti | 2005 |
The visualization of gastroenteropancreatic endocrine tumors.
Topics: Adenoma, Islet Cell; Carcinoid Tumor; Diagnostic Imaging; Gastrointestinal Neoplasms; Humans; Indium | 1993 |
Recent advances in diagnosis and therapy of neuroendocrine tumors of the gastrointestinal tract.
Topics: Adenoma, Islet Cell; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols | 1997 |
[The scintigraphy of somatostatin receptors in gastroenteropancreatic neuroendocrine tumors].
Topics: Gastrointestinal Neoplasms; Humans; Indium Radioisotopes; Neuroendocrine Tumors; Octreotide; Pancrea | 1997 |
Single photon emission computed tomography procedure improves accuracy of somatostatin receptor scintigraphy in gastro-entero pancreatic tumours.
Topics: Female; Gastrointestinal Neoplasms; Humans; Male; Neuroendocrine Tumors; Octreotide; Pancreatic Neop | 1999 |
[Scintigraphy of somatostatin receptors in the diagnosis and staging of neuroendocrine tumors of the digestive tract and pancreas].
Topics: Algorithms; Animals; Binding, Competitive; Biomarkers, Tumor; Clinical Trials, Phase I as Topic; Gas | 2000 |
Potential applications of monoclonal antibodies in cancer diagnosis and therapy.
Topics: Adenocarcinoma; alpha-Fetoproteins; Animals; Antibodies, Monoclonal; Antibody Specificity; Antigens, | 1985 |
2 trials available for pentetic acid and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
Scintigraphic detection of carcinoid tumors with a cost effectiveness analysis.
Topics: Adult; Aged; Carcinoid Tumor; Cost-Benefit Analysis; Female; Gastrointestinal Neoplasms; Humans; Ind | 2004 |
Comparison of iodine-123-vasoactive intestinal peptide receptor scintigraphy and indium-111-CYT-103 immunoscintigraphy.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Female; Gastrointestinal Neoplasms; Humans; Indium Radioisot | 1996 |
16 other studies available for pentetic acid and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Carcinoid Tumor; Chromogranin A | 2008 |
Treatment of advanced endocrine gastroenteropancreatic tumours using radiolabelled somatostatin analogues.
Topics: Antineoplastic Agents, Hormonal; Endocrine Gland Neoplasms; Gastrointestinal Neoplasms; Humans; Octr | 2005 |
Somatostatin receptor scintigraphy in carcinoids, gastrinomas and Cushing's syndrome.
Topics: Carcinoid Tumor; Cushing Syndrome; Gastrinoma; Gastrointestinal Neoplasms; Humans; Indium Radioisoto | 1994 |
[Somatostatin receptor scintigraphy in medullary thyroid carcinomas, GEP and carcinoid tumors].
Topics: Adult; Aged; Calcitonin; Carcinoembryonic Antigen; Carcinoid Tumor; Carcinoma, Medullary; False Posi | 1995 |
[Somatostatin receptor scintigraphy in preoperative diagnosis of the site of endocrine gastrointestinal tumors].
Topics: Biomarkers, Tumor; Carcinoid Tumor; Gastrinoma; Gastrointestinal Neoplasms; Humans; Indium Radioisot | 1994 |
Localization of gastroenteropancreatic neuroendocrine tumors with 111indium-pentetreotide scintigraphy.
Topics: Diagnostic Imaging; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Image Enhancement; Indium | 1994 |
Somatostatin receptor imaging in patients with neuroendocrine tumors: preoperative and postoperative scintigraphy and intraoperative use of a scintillation detector.
Topics: Adult; Aged; Carcinoid Tumor; Female; Follow-Up Studies; Gamma Cameras; Gastrointestinal Neoplasms; | 1994 |
Gastroenteropancreatic tumor imaging with somatostatin receptor scintigraphy.
Topics: Carcinoid Tumor; Gastrointestinal Neoplasms; Humans; Indium Radioisotopes; Neuroendocrine Tumors; Oc | 1994 |
Biodistribution of 111In-pentetreotide and dosimetric considerations with respect to somatostatin receptor expressing tumor burden.
Topics: Biomarkers, Tumor; Gastrointestinal Neoplasms; Humans; Indium Radioisotopes; Octreotide; Pancreatic | 1993 |
Receptor scintigraphy with 111In-pentetreotide for endocrine gastroenteropancreatic tumors.
Topics: Aged; Carcinoid Tumor; Gastrinoma; Gastrointestinal Neoplasms; Humans; Indium Radioisotopes; Insulin | 1993 |
111In-octreotide scintigraphy in oncology.
Topics: Apudoma; Gastrointestinal Neoplasms; Humans; Image Processing, Computer-Assisted; Indium Radioisotop | 1993 |
Internalization of indium-111 into human neuroendocrine tumor cells after incubation with indium-111-DTPA-D-Phe1-octreotide.
Topics: Autoradiography; Carcinoid Tumor; Gastrointestinal Neoplasms; Glucagonoma; Humans; Indium Radioisoto | 1996 |
64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors.
Topics: Adenoma, Islet Cell; Aged; Animals; Carcinoid Tumor; Female; Gastrointestinal Neoplasms; Humans; Ind | 2001 |
Role of (111)In-DTPA-pentetreotide scintigraphy in accurate diagnosis of neuroendocrine gastroenteropancreatic tumors.
Topics: Adult; Aged; Diagnosis, Differential; Gastrointestinal Neoplasms; Humans; Indium Radioisotopes; Male | 2001 |
[MRT of brain metastases. (I) What is the place of screening with T2-weighted sequences?].
Topics: Adult; Aged; Brain Neoplasms; Breast Neoplasms; Carcinoma, Bronchogenic; Gadolinium; Gadolinium DTPA | 1990 |
99mTc-DTPA uptake in malignant and inflammatory bowel disease: experience from gastrointestinal bleeding studies.
Topics: Adult; Aged; Colitis, Ulcerative; Colon; Crohn Disease; Female; Gastrointestinal Diseases; Gastroint | 1986 |